Euprotec is a leading and specialist provider of biology services to companies involved in the discovery and development of new drugs to treat infection, respiratory diseases and allergy.

The company has developed an extensive portfolio of assays and models related to:

Founded in 2008, Euprotec is built upon many years of internationally renowned expertise in microbiology and the development/validation of new efficacy models to better understand human disease and predict therapeutic outcome of drug candidates.